Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study | American Society of Nephrology
Neue Antikoagulanzien - Wann macht ein Drug-Monitoring Sinn? • doctors|today